Form 4: TransDigm Group CEO Kevin Stein Executes Stock Option and Sells Shares
SEC Form 4 Filing
CEO Kevin Stein exercised stock options and sold shares of TransDigm Group INC on February 12, 2025, according to a recent SEC Form 4 filing.
Summary
- On February 12, 2025, Kevin M Stein, President & CEO of TransDigm Group INC, exercised stock options for 20,000 shares at a price of $195.88 per share.
- Concurrently, Stein sold a total of 20,000 shares at varying prices ranging from $1,335.71 to $1,366.19.
- These transactions were conducted under a pre-arranged 10b5-1 trading plan.
- Following these transactions, Stein indirectly owns 113,500 derivative securities and 8,158 shares of common stock through the Fortuna Trust dated June 1, 2018.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions related to stock options and share sales, which are part of standard executive compensation practices.
Industry Context
Insider transactions are common and closely monitored, providing insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan suggests these transactions were pre-planned and not based on recent non-public information.
Comparison to Industry Standards
- Comparing these transactions to other aerospace and defense companies like Boeing, Lockheed Martin, or RTX Corporation, the scale of the transactions is relatively common for executive compensation and diversification strategies.
- The use of a 10b5-1 trading plan is a standard practice among executives to avoid accusations of insider trading, aligning with industry best practices.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased number of shares in the market.
- The transactions do not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| June 1, 2018 | Date of the Fortuna Trust |
| September 30, 2018 | Date the stock options became exercisable |
| April 25, 2028 | Expiration date of the stock options |
| February 12, 2025 | Date of stock option exercise and share sales |
| February 13, 2025 | Date of signature on the Form 4 filing |
Keywords
TransDigm Group, Kevin Stein, stock options, share sales, Form 4, insider trading, Fortuna Trust, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.